The following is attributed to Acting U.S. Food and Drug Administration (FDA) Commissioner Janet Woodcock, MD. The full press release about the first-ever action by the agency of this sort […]
People of color, those with a higher income, and younger individuals are more likely to participate in clinical trials during their cancer treatment, according to a new study from […]
When individuals with rare diseases or terminal illnesses do not meet the requirements for inclusion in a clinical trial that otherwise seems to offer hope for their condition, understanding the […]
Legislation currently under consideration in the U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at Massachusetts General Hospital (MGH) and colleagues […]
Making clinical trials more efficient, and ultimately more successful, would significantly advance patient care. However, fragmentation of the relevant data necessary to implement improvements to translational science is a significant […]